Sugi Predict

Sugi Predict / Compounds / SCHEMBL23213272

SCHEMBL23213272

SCHEMBL23213272

CC(C)(C)OC(=O)N1CC2(C[C@H](N3CCC(c4ccccc4CC4CCOCC4)CC3)CO2)C1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 7/20 0.53
▸ CHRM1 P11229 7/20 0.53
▸ CHRM2 P08172 2/20 0.40
▸ MAPT P10636 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ GPR119 Q8TDV5 1/20 0.37
▸ GAA P10253 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ NAMPT P43490 1/20 0.34
▸ KDM1A O60341 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ DRD2 P14416 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29871408 0.95 CHRM4 (0.49) CHRM4CHRM1CHRM2MAPTSMN1; SMN2
SCHEMBL29871491 0.92 CHRM4 (0.46) CHRM4CHRM1CHRM2MAPTSMN1; SMN2
SCHEMBL23213673 0.90 CHRM4 (0.59) CHRM4CHRM1CHRM2SMN1; SMN2GPR119
SCHEMBL30828944 0.87 CHRM4 (0.54) CHRM4CHRM1CHRM2KDM4EDRD2
SCHEMBL23212969 0.87 CHRM4 (0.54) CHRM4CHRM1CHRM2KDM4EDRD2
SCHEMBL23212972 0.87 CHRM4 (0.54) CHRM4CHRM1CHRM2KDM4EDRD2
SCHEMBL23212910 0.86 CHRM4 (0.54) CHRM4CHRM1CHRM2MAPTSMN1; SMN2
SCHEMBL29871490 0.85 CHRM4 (0.54) CHRM4CHRM1CHRM2GPR119IDO1
SCHEMBL23329023 0.84 CHRM4 (0.60) CHRM4CHRM1CHRM2GPR119KDM1A
SCHEMBL23213388 0.83 CHRM4 (0.58) CHRM4CHRM1CHRM2MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140959-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2024-05-02 — — US disclosed
US-11820778-B2 2-azaspiro[3.4]octane derivatives as M4 agonists NOVARTIS AG (CH) 2023-11-21 — — US disclosed
US-20220411435-A1 2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2022-12-29 — — US disclosed
US-11485742-B2 2-azaspiro[3.4]octane derivatives as M4 agonists NOVARTIS AG (CH) 2022-11-01 — — US disclosed
CN-114555606-A 5-oxa-2-azaspiro [3.4] octane derivatives as M4 agonists 诺华股份有限公司 2022-05-27 — — CN disclosed
WO-2021070091-A1 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11485742-B2 2-azaspiro[3.4]octane derivatives as M4 agonists CHRM2, CHRM1, CHRM3 CHRM4 4/4885CHRM1 2/4885CHRM2 1/4885
US-20240140959-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS CHRM2, CHRM1, CHRM3 CHRM4 4/4885CHRM1 2/4885CHRM2 1/4885
US-20220411435-A1 2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS CHRM2, CHRM1, CHRM3 CHRM4 4/4885CHRM1 2/4885CHRM2 1/4885
US-11820778-B2 2-azaspiro[3.4]octane derivatives as M4 agonists CHRM2, CHRM1, CHRM3 CHRM4 4/4885CHRM1 2/4885CHRM2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.